Researchers unveiled two new treatments for malaria as drug resistance grows globally.Novartis announced GanLum, effective against resistant malaria parasites, achieving a 99.2% cure rate in late-stage trials involving nearly 1,700 participants.Additionally, Dr. Ghyslain Mombo-Ngoma's research in Gabon reported a new single-dose combination treatment with a 93% parasite-free rate after 28 days, outperforming the traditional regimen.